Organon & Co.
OGNCIK 0001821825
Revenue (TTM)
$6.17B
−2.9% YoY
Q1 Apr 2026
Net Income (TTM)
$538M
−78.4% YoY
Q1 Apr 2026
EPS Diluted (TTM)
$2.05
−78.4% YoY
Q1 Apr 2026
Gross Margin
54.4%
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
8.7%
Q1 Apr 2026
Free Cash Flow (TTM)
$329M
Q1 Apr 2026
Cash
$1.12B
Q1 Apr 2026
Total Debt
$8.57B
Q1 Apr 2026
Shares Outstanding
262.6M sh
Q1 Apr 2026